MicroVision, RadNet And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Portfolio Pulse from Lisa Levin
Several big stocks are moving lower in Wednesday's pre-market session, including MicroVision, RadNet, Logitech, Kura Oncology, Humana, Beneficient, and UnitedHealth Group.
June 14, 2023 | 10:50 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Beneficient shares fell 4.1% after dropping 14% on Tuesday.
The article does not provide a specific reason for the drop in Beneficient's stock price, but it could be due to market sentiment or other factors.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Humana shares dropped 4.6% in pre-market trading.
The article does not provide a specific reason for the drop in Humana's stock price, but it could be due to market sentiment or other factors.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Kura Oncology shares fell 7.9% after reporting commencement of $100 million public offering of common stock and pre-funded warrants.
The public offering could lead to dilution of existing shares, causing the stock price to drop in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Logitech shares dropped 9% after announcing President and CEO Bracken Darrell's departure.
The departure of the CEO could create uncertainty about the company's future direction, causing the stock price to drop in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
MicroVision shares dropped 12.7% after filing for a mixed shelf offering.
The mixed shelf offering could lead to dilution of existing shares, causing the stock price to drop in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
RadNet shares fell 9% after pricing an underwritten offering of 7.575 million shares at $29.75 per share.
The underwritten offering could lead to dilution of existing shares, causing the stock price to drop in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
UnitedHealth Group shares declined 3.8% after CEO flagged elevated volumes of non-urgent surgeries at analyst conference.
The increase in non-urgent surgeries could lead to higher costs for the company, causing the stock price to drop in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100